Dermatology Drug Development Summit Europe
May 21 - 23, 2019 - Frankfurt am Main DEHanson Wade
info@hansonwade.com
Phone:2031418700
The Dermatology Drug Development Series is a unique industry-focused, dedicated discussion and networking forum committed to addressing the key challenges and advances in dermatology drug development and commercialisation. Following two successful editions in Boston, this series now makes its debut in Europe, to provide the European dermatology community with a unique end-toend platform to discuss and learn about the latest insights on how to accelerate preclinical and translational research, clinical development, approval and commercial activities of dermatological therapeutics. Join your peers and hear from a faculty of expert leaders including Sanofi, LEO Pharma and UCB, who will be sharing their learning and latest case-studies. You’ll leave this meeting with the knowledge and connections to successfully advance your work in dermatology drug development at your own organisation. Key highlights include: - Glenmark Pharmaceuticals and LEO Pharma explore key translational challenges in dermatology, including in-vitro systems and animal models. - Kymab and Temesis Therapeutics share their experience with new target development in atopic dermatitis and psoriasis, respectively. - ProQR Therapeutics and University of Modena and Reggio Emilia address the development of innovative treatments targeting dermatological rare diseases. - Sanofi, Celgene and Galderma discuss the current landscape in dermatology drug development, including the latest biologic approaches, unmet needs, value demonstration and commercial hurdles. - Sol-Gel Technologies, Sienna Biopharmaceuticals and Botanix Pharmaceuticals share their latest advances into topical development and formulation approaches. Early booking and group discounts apply, start-up and academic rates are available - see the website for details.